Supporting Multiple Global Gene Therapy Studies For Rare Diseases
Source: Veristat, Inc.

A long-term client called upon the Veristat team for help conducting two investigational Phase I/II studies. These global studies focused on proving the safety and efficacy of gene therapy for two rare genetic disorders. Working side-by-side with the client, our cell and gene therapy experts addressed many complicated challenges – including site start-up issues, stringent regulatory requirements, and the logistics of handling highly sensitive genetic material.
Study Demographics
Rare Disease Global Trials - Multiple Phase I/II studies across the US, Canada, Australia and Israel
Primary Services Provided:
- Regulatory Consulting
- Adaptive Design Planning
- Project Management
- Monitoring
- Biometrics
- Data Management
- Medical Monitoring
- Safety Oversight
- Medical Writing
- Submissions
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Cell & Gene? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Veristat, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more